معرفی
Professor Moin Saleem serves as a Professor at Bristol Medical School, University of Bristol, specializing in nephrology and kidney disease research. He concurrently holds the position of Chief Scientific Officer at Purespring Therapeutics Ltd since February 2021.
Education
- M.B., B.S.
- Ph.D. (London)
- Fellow of the Royal College of Physicians (F.R.C.P.)
Research Interests: His work centers on podocyte biology, genetic kidney disorders, and renal pathophysiology, with emphasis on molecular mechanisms in nephrotic syndrome and tubular acidosis. Integrating biochemistry and genetics, his research identifies biomarkers for disease progression and treatment response in chronic kidney conditions.
Publication Trends: Recent 2025 publications demonstrate sustained focus on genetic variants in renal tubular disorders, longitudinal analysis of nephrotic syndrome outcomes, and mortality biomarkers in chronic kidney disease, reflecting clinical-translational research priorities.
Scientific Awards
- Fellow of the Royal College of Physicians
Advising and Grants: Professor Saleem has supervised 8 students. As Principal Investigator, he secured 12 projects including MRC-funded research on DNA methylation in paediatric nephrotic syndrome (2021-2024) and two MRC Pathfinder to Discovery grants in 2019, demonstrating consistent funding success in genetic kidney research.
Labs and Teams: His research group, evidenced by topic fingerprinting, maintains a specialized focus on podocyte biochemistry and molecular genetics with extensive international collaborations across 12 similar research profiles.
